Electronic versions



Background: All health care systems face the need to find the resources to meet new demands such as a new, cost-increasing health technology. In England and Wales, when a health technology is recommended by the National Institute for Health and Care Excellence (NICE), the National Health Service (NHS) is mandated to provide the funding to accommodate it within three months of publication of the recommendation. Identifying what, in practice, is foregone when new cost-increasing technologies are introduced is important for understanding the effects of health technology assessment (HTA) decisions on the NHS or any other health care system. Our objective was to investigate how in practice local NHS commissioners in Wales accommodated financial “shocks” arising from technology appraisals (TAs) issued by NICE and from other cost pressures.


  • Opportunity costs, Priority setting, Cost-effectiveness, Health Technology Assessment, National Health Service, All Wales Medicines Strategy Group, National Institute for Health and Care Excellence
Original languageEnglish
JournalBMC Health Services Research
Issue number103
Publication statusPublished - 25 Mar 2016

Total downloads

No data available
View graph of relations